Skip to main content
CRBP
NASDAQ Life Sciences

Corbus Shares Plunge 31% on Adverse Events in Key Tumor Drug Study

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$7.81
Mkt Cap
$144.702M
52W Low
$6.72
52W High
$20.56
52W Position info
16% above low
Off High info
62% below high
Rel. Volume info
9.5× avg
Market data snapshot near publication time

CRBP sits 16% above its 52-week low of $6.72 on elevated volume (9.5× avg).

Summary

Corbus Pharmaceuticals shares plummeted 31% today following reports of adverse events in its Phase 1/2 clinical study for CRB-701, a lead oncology drug. The data revealed Grade 3 treatment-related adverse events in 19.2% of patients and life-threatening Grade 4 events in 0.9%. This negative market reaction comes despite earlier announcements today from the company and an 8-K filing that emphasized positive aspects of the same clinical data. The significant safety concerns, particularly the Grade 4 events, are weighing heavily on the stock and raise questions about the drug's future, even as the company maintains CRB-701 is safe and on track for a registrational study in summer 2026.

At the time of this announcement, CRBP was trading at $7.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $144.7M. The 52-week trading range was $6.72 to $20.56. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

CRBP - Latest Insights

CRBP
Nov 16, 2026, 8:08 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.45
Real-time Price: $3.07 info
Change: -$0.3775 (-11%) info
Market Cap: $62.026M info
CRBP
Nov 10, 2026, 8:08 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.52
Real-time Price: $3.07 info
Change: -$0.450 (-13%) info
Market Cap: $62.026M info
CRBP
Sep 29, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.08
Real-time Price: $3.07 info
Change: -$4.01 (-57%) info
Market Cap: $62.026M info
CRBP
Sep 14, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.26
Real-time Price: $3.07 info
Change: -$6.19 (-67%) info
Market Cap: $62.026M info
CRBP
Sep 14, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $8.91
Real-time Price: $3.07 info
Change: -$5.84 (-66%) info
Market Cap: $62.026M info